DexCom, Inc. (ETR:DC4)

Germany flag Germany · Delayed Price · Currency is EUR
71.60
+0.18 (0.25%)
Last updated: May 5, 2025
-38.86%
Market Cap 28.22B
Revenue (ttm) 3.84B
Net Income (ttm) 495.17M
Shares Out n/a
EPS (ttm) 1.23
PE Ratio 57.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 105
Open 71.47
Previous Close 71.42
Day's Range 71.47 - 71.60
52-Week Range 52.00 - 120.94
Beta n/a
RSI 63.30
Earnings Date May 1, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 10,300
Stock Exchange Deutsche Börse Xetra
Ticker Symbol DC4
Full Company Profile

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD Financial Statements

News

There is no news available yet.